Queen Mary University London notified Nature and University College London that there is reason to question the provenance of the data for Fig. 5b, d, e of this Letter (Fig. 5a, c data are unaffected). Ongoing studies are investigating the reported effect of p110δ inhibition in the pancreatic cancer mouse model. We therefore wish to withdraw these figure panels and associated text from the published paper. This does not affect the overall conclusion of the manuscript or any of the other experiments performed for this study as they repeat effects shown using other model systems in the paper (see Supplementary Information for raw data of experiments). We apologise for the inconvenience that this may have caused.
The online version of the original article can be found at 10.1038/nature13444
This zipped file contains the raw data of the experiments (other than those shown in Fig. 5b, d, e). The raw data are presented as follows: Excel, Word and PDF files capture the experimental schedules, study design and experimental data gathered (for example, survival data, tumour size measurements, autopsy data, pathology report, cytokine production). The GraphPad Prism files capture the relevant values obtained from the experiments, their associated statistical analyses and graphs. The raw data are organised in folders, each of which represents a figure panel. (ZIP 7740 kb)
About this article
Cite this article
Ali, K., Soond, D., Piñeiro, R. et al. Correction: Corrigendum: Inactivation of PI(3)K p110δ breaks regulatory T-cell-mediated immune tolerance to cancer. Nature 535, 580 (2016). https://doi.org/10.1038/nature17641